Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100498003 | 10049800 | 3 | F | 20100201 | 20150917 | 20140401 | 20150930 | EXP | DE-BEH-2014041463 | CSL BEHRING | 32.80 | YR | F | Y | 64.00000 | KG | 20150930 | N | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100498003 | 10049800 | 1 | PS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 1.7 ML/MIN, INFUSION RATE MAX. 4.3 ML/MIN | D | 4328400005 | 125201 | 10 | G | ||||||
| 100498003 | 10049800 | 2 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 5 ML/MIN | D | 125201 | 25 | G | |||||||
| 100498003 | 10049800 | 3 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 5 ML/MIN | D | 4328500005 | 125201 | ||||||||
| 100498003 | 10049800 | 4 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 5 ML/MIN | D | 4328300004 | 125201 | ||||||||
| 100498003 | 10049800 | 5 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 125201 | 25 | G | |||||||
| 100498003 | 10049800 | 6 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 4328400005 | 125201 | ||||||||
| 100498003 | 10049800 | 7 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 4328500005 | 125201 | ||||||||
| 100498003 | 10049800 | 8 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 125201 | 25 | G | |||||||
| 100498003 | 10049800 | 9 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 4328500004 | 125201 | ||||||||
| 100498003 | 10049800 | 10 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 4328300003 | 125201 | ||||||||
| 100498003 | 10049800 | 11 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 125201 | 25 | G | |||||||
| 100498003 | 10049800 | 12 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 4328500005 | 125201 | ||||||||
| 100498003 | 10049800 | 13 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 4328300004 | 125201 | ||||||||
| 100498003 | 10049800 | 14 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 125201 | 25 | G | |||||||
| 100498003 | 10049800 | 15 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 4328500005 | 125201 | ||||||||
| 100498003 | 10049800 | 16 | SS | PRIVIGEN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | INFUSION RATE: MIN. 3 ML/MIN, INFUSION RATE MAX. 4 ML/MIN | D | 4328300004 | 125201 | ||||||||
| 100498003 | 10049800 | 17 | SS | HAEMATE P | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | D | 0 | TIW | |||||||||
| 100498003 | 10049800 | 18 | SS | HAEMATE P | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | D | 0 | 1000 | IU | ||||||||
| 100498003 | 10049800 | 19 | SS | HAEMATE P | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | D | 0 | 6000 | IU | ||||||||
| 100498003 | 10049800 | 20 | SS | HAEMATE P | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | D | 0 | 7000 | IU | ||||||||
| 100498003 | 10049800 | 21 | SS | HAEMATE P | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | D | 0 | 7000 | IU | ||||||||
| 100498003 | 10049800 | 22 | SS | HAEMATE P | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | D | 0 | 5000 | IU | ||||||||
| 100498003 | 10049800 | 23 | SS | HAEMATE P | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | D | 0 | 3000 | IU | ||||||||
| 100498003 | 10049800 | 24 | SS | HAEMATE P | ANTIHEMOPHILIC FACTOR HUMAN | 1 | Intravenous (not otherwise specified) | D | 0 | TIW | |||||||||
| 100498003 | 10049800 | 25 | SS | Fibrogammin | FACTOR XIII CONCENTRATE (HUMAN) | 1 | Intravenous (not otherwise specified) | D | 0 | 2500 | IU | ||||||||
| 100498003 | 10049800 | 26 | SS | Fibrogammin | FACTOR XIII CONCENTRATE (HUMAN) | 1 | Intravenous (not otherwise specified) | D | 0 | 2500 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100498003 | 10049800 | 2 | Immunodeficiency common variable |
| 100498003 | 10049800 | 17 | Von Willebrand's disease |
| 100498003 | 10049800 | 25 | Factor XIII deficiency |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100498003 | 10049800 | Exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100498003 | 10049800 | 1 | 20100201 | 20100201 | 0 | |
| 100498003 | 10049800 | 2 | 20100217 | 20100217 | 0 | |
| 100498003 | 10049800 | 3 | 20100217 | 20100217 | 0 | |
| 100498003 | 10049800 | 4 | 20100217 | 20100217 | 0 | |
| 100498003 | 10049800 | 5 | 20100224 | 20100224 | 0 | |
| 100498003 | 10049800 | 6 | 20100224 | 20100224 | 0 | |
| 100498003 | 10049800 | 7 | 20100224 | 20100224 | 0 | |
| 100498003 | 10049800 | 8 | 20100305 | 20100305 | 0 | |
| 100498003 | 10049800 | 9 | 20100305 | 20100305 | 0 | |
| 100498003 | 10049800 | 10 | 20100305 | 20100305 | 0 | |
| 100498003 | 10049800 | 11 | 20100317 | 20100317 | 0 | |
| 100498003 | 10049800 | 12 | 20100317 | 20100317 | 0 | |
| 100498003 | 10049800 | 13 | 20100317 | 20100317 | 0 | |
| 100498003 | 10049800 | 14 | 20100419 | 20100419 | 0 | |
| 100498003 | 10049800 | 15 | 20100419 | 20100419 | 0 | |
| 100498003 | 10049800 | 16 | 20100419 | 20100419 | 0 | |
| 100498003 | 10049800 | 17 | 20100128 | 0 | ||
| 100498003 | 10049800 | 19 | 20100217 | 20100217 | 0 | |
| 100498003 | 10049800 | 20 | 20100224 | 20100224 | 0 | |
| 100498003 | 10049800 | 21 | 20100305 | 20100305 | 0 | |
| 100498003 | 10049800 | 22 | 20100317 | 20100317 | 0 | |
| 100498003 | 10049800 | 23 | 20100419 | 20100419 | 0 | |
| 100498003 | 10049800 | 24 | 20100927 | 0 | ||
| 100498003 | 10049800 | 25 | 20100707 | 20100707 | 0 | |
| 100498003 | 10049800 | 26 | 20100822 | 20100822 | 0 |